MedTrace Logo

TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence

NCT04221126 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-01-09

No results posted yet for this study

Summary

This study investigates a relatively new device TMFI and incubation of ALA in a cream-vehicle and a gel-vehicle.

Conditions

  • Normal Skin

Interventions

DEVICE

TMFI

Tixel rapidly transfer thermal energy by a metallic pyramid tip that enable skin contact through integrated pulsed movements. The rapid heating dehydrates he epidermis and superficial dermis and creates micropores with no coagulative damage of surronding tissue.

DRUG

ALA cream

ALA compounded in a cream

DRUG

ALA gel

ALA compounded in a gel

Sponsors & Collaborators

  • Merete Haedersdal

    lead OTHER

Principal Investigators

  • Merete Hædersdal, DMSc · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-29
Primary Completion
2019-08-08
Completion
2019-12-09

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04221126 on ClinicalTrials.gov